LITTLE KNOWN FACTS ABOUT REMODELIN.

AP-III-a4Subgroup 2: Patients previously treated with NaPBA but who discontinued treatment due to uncontrolled ammonia ranges or were being unable to tolerate NaPBA, with disease onset after two several years previous. This subgroup compared GPB with dietary Command by itself.The study was initially created to establish an RP2D using a day 1 and ei